3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-benzamide, 95.0%, 25g

5-Chloro-6-fluoro-1-benzofuran-2-carboxylic acid, 95%, 50mg

1-(1-Methyl-1H-pyrazol-4-yl)ethanol, 95.0%, 1g

Maltotetraose, 99.59%, 25mg

Phthalic Hydrazide>98.0%(HPLC)(T)25g

Triethylamine hydrochloride; 98%, 98.0%, 250g

(2E)-3-[4-(hydroxymethyl)-2-thienyl]acrylic acid, 95.0%, 10g

Triethylene Glycol Monobutyl Ether>98.0%(GC)500mL

tert-butyl 5-bromo-1,2,3,4-tetrahydropyridine-1-carboxylate, 97.0%, 5g

Potassium metaborate hydrate, = 31% as B2O3 & = 42% as K2O, 25g

1-Benzyl-5-nitro-1H-imidazole, 95.0%, 25g

3-Fluoro-2-[(piperidin-4-yl)methoxy]pyridine dihydrochloride, 1g

2-(3-((3,4-Dichlorobenzyl)oxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 100mg